Articles | Volume 10, issue 2
https://doi.org/10.5194/jbji-10-143-2025
https://doi.org/10.5194/jbji-10-143-2025
Review
 | 
08 Apr 2025
Review |  | 08 Apr 2025

Oral tetracyclines for bone and joint infections: what do we know?

Tom Cartau, Jocelyn Michon, Renaud Verdon, and Aurelie Baldolli

Viewed

Total article views: 196 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
171 21 4 196 2 2
  • HTML: 171
  • PDF: 21
  • XML: 4
  • Total: 196
  • BibTeX: 2
  • EndNote: 2
Views and downloads (calculated since 08 Apr 2025)
Cumulative views and downloads (calculated since 08 Apr 2025)

Viewed (geographical distribution)

Total article views: 195 (including HTML, PDF, and XML) Thereof 195 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 19 Apr 2025
Download
Short summary
Bone and joint infections are common and generally require surgical treatment combined with prolonged antibiotic therapy. It is important to use an antibiotic with good bone penetration that is effective against the commonly encountered pathogens and well-tolerated. Oral tetracyclines are promising and frequently used candidates. This review summarizes the available data on the use of oral tetracyclines in bone and joint infections and highlights the limited data available.
Share